Navigation Links
Virus Helps Remove Brain Cancer

Researchers at University of Texas have tested a novel "viral smart bomb" therapy that can completely eradicate brain tumors in mice, while leaving normal brain tissue alone. The Delta-24-RGD therapy, becomes the first treatment for the deadliest brain cancer, the malignant glioma. It is a new-generation "replication-competent oncolytic" adenovirus therapy in which a therapeutic virus spreads throughout a tumor, infecting and killing cancer cells. Delta-24-RGD is designed in such a way that it can replicate only in cancer// cells leaving behind healthy tissue. It kills the host cancer cells for reproducing itself. It moves on to contaminate other tumor cells, and when no more cancer cells are left to infect, the virus itself dies.

Researchers at the University of Alabama at Birmingham and the Institute of Catalá d'Oncologia in Barcelona, Spain, found in repeated experiments that more than half of mice that had human glioblastoma tumors implanted in their brains and treated with Delta-24-RGD survived for more than four months, whereas untreated mice lived for less than three weeks. Many experiments have been conducted since this study and they all produced similar results.
'"/>




Page: 1

Related medicine news :

1. Virus Level could Predict Cervical Cancer Risk
2. Ebola Virus - Outbreak Claims More Lives In Uganda.
3. Experimental treatment for Ebola Virus Shows promising results in mice
4. Virus Combats Brain Tumour
5. Virus killer
6. Pain Killers Keep the Virus Away
7. Measles Suppresses AIDS Virus
8. Virus connection to cervical injury
9. Origin Of SARS Virus Discovered
10. New Molecule that can stop the growth of Viruses
11. The Possibility Of Fighting HIV with Another Virus Questioned

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Virus Helps Remove Brain Cancer

(Date:11/26/2009)...enton Communications announces a highly effective ...ilers struggling to make an economic recovery. , ...-- Flu fears is the type of challenge that could s...cording to Dr. David Benton, business growth exper... system – The Rfactor Intensive . “...
(Date:11/25/2009)...25/PRNewswire/--TheBartleHallConventionCenterwillt...ec.9-10,whenKansasCityhoststhelatestinaseriesofmas...cliniceventhasthepotentialtobethebiggestoneyet,bec...ldonweekdaysinsteadofoveraweekend,"SheriWood,execu...identoftheNationalAssociationofFreeClinics(NAFC). ...
(Date:11/25/2009)...wswire/-SentinelleMedicalInc.,aleadingmanufacturer...unchesasuiteofnewleadingedgeclinicalapplicationson...ar,sRadiologicalSocietyofNorthAmerica(RSNA)annualm....Theapplicationsleveragetheuniquehighqualityimages...ndsupportmultipleimagingmodalitiesformulti-paramet...
(Date:11/25/2009)...RNewswire-USNewswire/--TheBlackAIDSInstituterecent...leadershipfor2010. ,, ThenewBoardMembersareahig...icy,law,finance,governmenthealthprograms,editorial...awiderangeofpersonalbackgroundsincludingbothhetero...selves,andrepresentingmultipleagegroups. ,, (Ph...
(Date:11/25/2009)...sticular cancer who were treated with cisplatin-ba...luding neurological side effects and Raynaud-like ...otherapy, according to a new study published onlin...er Institute . , Marianne Brydy, M.D., of the De...l, in Bergen, Norway, and colleagues conducted a c...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2
...ence Call to be held on November 13, 2007 at 8:00 ...eijing/Hong Kong), SHANGHAI, China, Oct. 23 /Xinh...SE: WX ) ("WuXi PharmaTech" or "the Company"), th...nancial results for the third quarter ended Septem...
...Oct. 23 Aflac Incorporated,today reported its thi...e dollar, total revenues rose 5.1% to $3.9,billion...3.7 billion in the,third quarter of 2006. Net earn...t gains of $1 million, or nil per,diluted share, c...
...ich.---Firing clay in unvented kilns could be a si...larly and over long periods, a new study suggests....ith subjects who participated in the University of...naw. , The two-year study, commissioned by Dow Ch...
...ging Identifies Sleep Disorder Without Disturbing ...ly diagnosed by,way of measuring airflow by nasal ...ugh sensors placed in the nose. However, this meth...mbly,of the American College of Chest Physicians (...
.... 23 Two carotid stenting,trials examining outcom...st,time results that are comparable to guidelines ...)(1) for patients treated with carotid artery,surg...ual Transcatheter Cardiovascular Therapeutics (TCT...
...nched to Provide Information and Product Acquisiti...dlines of,the recent tragedies caused by Community... Solutions, LLC, part of the Key Medical Group of,...ucts to combat and kill these superbugs. The websi...
Other Medicine News:Health News:WuXi PharmaTech Schedules 2007 Third Quarter Earnings Release on Monday, November 12, 2007 2Health News:WuXi PharmaTech Schedules 2007 Third Quarter Earnings Release on Monday, November 12, 2007 3Health News:Aflac Incorporated Announces Third Quarter Results, Declares Fourth Quarter Cash Dividend 2Health News:Aflac Incorporated Announces Third Quarter Results, Declares Fourth Quarter Cash Dividend 3Health News:Aflac Incorporated Announces Third Quarter Results, Declares Fourth Quarter Cash Dividend 4Health News:Aflac Incorporated Announces Third Quarter Results, Declares Fourth Quarter Cash Dividend 5Health News:Aflac Incorporated Announces Third Quarter Results, Declares Fourth Quarter Cash Dividend 6Health News:Aflac Incorporated Announces Third Quarter Results, Declares Fourth Quarter Cash Dividend 7Health News:Aflac Incorporated Announces Third Quarter Results, Declares Fourth Quarter Cash Dividend 8Health News:Aflac Incorporated Announces Third Quarter Results, Declares Fourth Quarter Cash Dividend 9Health News:Aflac Incorporated Announces Third Quarter Results, Declares Fourth Quarter Cash Dividend 10Health News:Aflac Incorporated Announces Third Quarter Results, Declares Fourth Quarter Cash Dividend 11Health News:Aflac Incorporated Announces Third Quarter Results, Declares Fourth Quarter Cash Dividend 12Health News:Firing clay in unvented kilns may be a source of exposure to dioxins 2Health News:Infrared Imaging for Sleep Apnea Diagnosis Shows Promise 2Health News:Infrared Imaging for Sleep Apnea Diagnosis Shows Promise 3Health News:Real-World Studies of Carotid Artery Stenting Demonstrate Results Comparable to Guidelines for Patients Treated With Surgery 2Health News:Real-World Studies of Carotid Artery Stenting Demonstrate Results Comparable to Guidelines for Patients Treated With Surgery 3Health News:Real-World Studies of Carotid Artery Stenting Demonstrate Results Comparable to Guidelines for Patients Treated With Surgery 4Health News:Key Cleaning Solutions Products Utilized to Combat Community Acquired - MRSA (CA-MRSA) Are Succeeding In Killing Superbugs Where Normal Cleaning Practices and Products Are Not 2Health News:Key Cleaning Solutions Products Utilized to Combat Community Acquired - MRSA (CA-MRSA) Are Succeeding In Killing Superbugs Where Normal Cleaning Practices and Products Are Not 3
(Date:11/25/2009)... ,, NEWYORK,Nov.25/PRNewswire/--Reportlinker...leinitscatalogue: ,, PainManagement-GlobalTre...Pain-Management---Global-Trends.html ,, Widesp...gementclinics,andtheadventofnewdrugshaveaccelerate...rereformsandreimbursementstructurecontinuetoshaped...
(Date:11/25/2009)... ,, FRAMINGHAM,Mass.andSYDNEY,Nov.25/PRNewsw...: HTWR ;ASX:HIN),aleadinginnovatorandproviderofles...esrevolutionizingthetreatmentofadvancedheartfailur...resentationatthe21stAnnualPiperJaffrayHealthCareCo...onferenceisbeingheldattheNewYorkPalaceHotel,Decemb...
(Date:11/24/2009)... ,, PITTSBURGH,Nov.24/PRNewswire/-- ,, WH...r23yearsfollowinganautoaccident,wasactuallyfullyco...odMorningAmericasegment.TheDynaVoxEyeMaxwasfeature...dromeandotherconditionscanunlockcommunication. ,...ailableonlineat www.dynavoxtech.com ,, W...
Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2VetCentric Partners with Elanco Animal Health 54326 1VetCentric Partners with Elanco Animal Health 54326 2Verizon Wireless Offers Healthy Applications to Turn a Mobile Phone Into a Personal Trainer 54323 1Verizon Wireless Offers Healthy Applications to Turn a Mobile Phone Into a Personal Trainer 54323 2New Evidence Based Research Shows that Universal Comprehensive Eye Exams Would Help More Children Succeed in School 54320 1New Evidence Based Research Shows that Universal Comprehensive Eye Exams Would Help More Children Succeed in School 54320 2New Evidence Based Research Shows that Universal Comprehensive Eye Exams Would Help More Children Succeed in School 54320 3New Evidence Based Research Shows that Universal Comprehensive Eye Exams Would Help More Children Succeed in School 54320 4
...published in,EuroIntervention showed that the expe...ir with the MitraClip(R) system to correct mitral ...ly significant mitral stenosis. Additionally,with ...ed with the,MitraClip(R) system required surgery f...erences were reported between the use of one or tw...
...Clinical Trials , , SAN DIEGO, Dec. 4 VentiR...ny focused on the development of novel Toll-Like R...cer, respiratory and autoimmune diseases, announce...rial of VTX-2337, a selective TLR8 agonist for the...rial is being conducted at the Mayo Clinic Arizona...
Other Medicine Technology:Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System 2Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System 3Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System 4VentiRx Pharmaceuticals Commences Phase I Clinical Trial of VTX-2337, a Novel TLR8 Agonist for the Treatment of Oncology 2
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products: